Pain relief shot for hysterectomy patients put on hold
NCT ID NCT05823363
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if injecting Exparel (a long-acting painkiller) into the vaginal cuff before a minimally invasive hysterectomy could lower pain scores. Participants would have reported pain levels and medication use. However, the trial was withdrawn before any patients enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Exparel (liposomal bupivacaine) mixed with bupivacaine
- What this could lead to
- If it worked, this could offer a way to reduce pain after hysterectomy without strong opioids.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no results are available. Even if run, it was a small Phase 4 study testing a known drug for a new use, so benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maimonides Medical Center
Brooklyn, New York, 11219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can patients safely dispense their own pain medicine after surgery?
- Can a VR headset calm nerves before surgery?
- Can a less invasive nerve block match the gold standard for chest surgery pain?
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- One injection or many? a test to ease breast surgery pain
- One injection vs. two: a new approach to shoulder surgery pain?